W
Winfried Häuser
Researcher at Technische Universität München
Publications - 389
Citations - 19998
Winfried Häuser is an academic researcher from Technische Universität München. The author has contributed to research in topics: Fibromyalgia & Chronic pain. The author has an hindex of 61, co-authored 361 publications receiving 15838 citations. Previous affiliations of Winfried Häuser include University of Duisburg-Essen.
Papers
More filters
Journal ArticleDOI
All-cause mortality in patients with long-term opioid therapy compared with non-opioid analgesics for chronic non-cancer pain: a database study
Winfried Häuser,Tino Schubert,Tobias Vogelmann,Christoph Maier,Mary-Ann Fitzcharles,Thomas R. Tölle +5 more
TL;DR: LTOT for CNCP compared to non-opioid analgesics was associated with an increased risk for all-cause mortality and a propensity score matching model indicated a good classification, residual confounding cannot be fully excluded.
Journal ArticleDOI
Long-term opioid therapy for chronic noncancer pain: second update of the German guidelines.
Frank Petzke,F. Bock,Michael Hüppe,Monika Nothacker,Heike Norda,Lukas Radbruch,Marcus Schiltenwolf,Matthias Schuler,Thomas R. Tölle,Anika Viniol,Winfried Häuser +10 more
TL;DR: Neither uncritical opioid prescription nor general rejection of opioids is justified in patients with chronic noncancer pain.
Journal ArticleDOI
Validation of the Turkish version of the Celiac Disease Questionnaire (CDQ)
TL;DR: The Turkish version of the Celiac Disease Questionnaire (CDQ) proved to be a reliable and valid instrument for measuring HRQOL in Turkish patients with celiac disease.
Journal Article
Is the association of self-reported childhood maltreatments and adult fibromyalgia syndrome attributable to depression? A case control study.
Winfried Häuser,Daniela Bohn,Hedi Kühn-Becker,Rosemarie Erdkönig,Elmar Brähler,Heide Glaesmer +5 more
TL;DR: The difference in self-reported childhood sexual abuse between adult FMS-patients and population controls was not attributable to depression, and reports of FMS -patients some on childhood maltreatments were biased by depressed mood.
Journal ArticleDOI
A cautious hope for cannabidiol (CBD) in rheumatology care
TL;DR: Cannabidiol (CBD), a major metabolite of Cannabis sativa, is popularized as a medicinal product, with potential for analgesic, anti-inflammatory and antioxidant effects, but evidence to date remains preclinical.